MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $932,184 | +290.9% | 21,400 | +224.2% | 0.01% | +350.0% |
| Q2 2023 | $238,458 | -49.8% | 6,600 | -2.9% | 0.00% | -60.0% |
| Q3 2022 | $474,912 | +92.3% | 6,800 | +126.7% | 0.01% | +150.0% |
| Q1 2022 | $247,000 | -57.9% | 3,000 | -25.0% | 0.00% | -50.0% |
| Q4 2021 | $587,000 | +21.0% | 4,000 | +33.3% | 0.00% | -20.0% |
| Q2 2021 | $485,000 | -19.2% | 3,000 | -14.3% | 0.01% | -16.7% |
| Q1 2021 | $600,000 | -9.0% | 3,500 | +16.7% | 0.01% | -14.3% |
| Q4 2020 | $659,000 | +16.6% | 3,000 | -11.8% | 0.01% | +16.7% |
| Q3 2020 | $565,000 | +5.2% | 3,400 | -27.7% | 0.01% | 0.0% |
| Q2 2020 | $537,000 | +39.8% | 4,700 | -6.0% | 0.01% | +20.0% |
| Q1 2020 | $384,000 | – | 5,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |